REVELATION BIOSCIENCES, INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Nov 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $1.9M | — | $1.4M | — | — | — | $922.9K |
| SG&A Expense | — | $1.7M | — | $1.7M | — | — | — | $1.0M |
| Operating Income | — | $-3.7M | — | $-3.1M | — | — | — | $-1.9M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | $0 |
| Net Income | — | $-3.3M | — | $-3.0M | — | — | — | $-1.9M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $-0.87 | — | $-2.71 | — | — | — | $-0.04 |
| EPS (Diluted) | — | $-0.87 | — | $-2.71 | — | — | — | $-0.04 |
| Shares Outstanding (Basic) | 4.0M | 3.8M | 3.9M | 3.2M | 3.7M | 1.6M | 254.7M | 113.7M |
| Shares Outstanding (Diluted) | 4.0M | 3.8M | 3.9M | 3.2M | 3.7M | 1.6M | 254.7M | 113.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |